What are your priorities for your clinical trial supply in 2013?
Download this report and discover how to:
- Reduce overage through implementing product pooling and just in time labelling with strategies from our expert advisory panel
- Leverage outsourcing opportunities by learning best practice in distribution and logistics
- Get to grips with GDP regulations to understand the latest requirements for controlled room temperature
4 Key findings from the report include:
- Supporting numerous clinical trials is the main priority for respondents for the next 5 years
- 42% run between 1 and 10 active trials annually
- 71% predict the number of trials in BRIC countries to increase in the next 12 mont
- China was selected as the most likely popular destination for clinical trials in the next 5 years at 35.4%
| Have Your Say Rate this feature and give us your feedback in the comments section below |